Showing 421-430 of 1539 results for "".
“No Drug is 100 Percent.”
https://practicaldermatology.com/conferences/maui-derm-2024/no-drug-is-100-percent/20242/Jason Hawkes, MD and Chief Medical Editor Neal Bhatia, MD discuss how the current array of options for patients of chronic spontaneous urticaria (CSU) expand treatment options for hives beyond antihistamines.Viewpoints : Too Many People with Dermatologic Diseases Are Excluded from Drug Innovation. Let’s Change Thathttps://practicaldermatology.com/topics/psoriasis/iviewpointsi-too-many-people-with-dermatologic-diseases-are-excluded-from-drug-innovation-lets-change-that/23713/UCB: Committed to Driving Immuno-dermatology Forward
https://practicaldermatology.com/topics/psoriasis/ucb-committed-to-driving-immuno-dermatology-forward/23327/The Science Driving Topicals Into the Future
https://practicaldermatology.com/topics/psoriasis/the-science-driving-topicals-into-the-future/19721/On the therapeutic front, one topic Neal Bhatia, MD is paying particularly close attention to is recent advances in vehicle science, which offer novel and intriguing strategies to improve delivery of topical applications to and through the skin.New Drugs for Treating Fungal Infections
https://practicaldermatology.com/topics/general-topics/new-drugs-for-treating-fungal-infections/21426/A review of recent developments for efficacious treatment.Can UV Nail Dryers Cause Skin Cancer?
https://practicaldermatology.com/topics/hair-nails/can-uv-nail-dryers-cause-skin-cancer/23898/Alexis Livingston Young, MD, weighs in on the evidence.FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-drug-prurigo-nodularis-long-term-use-dupilumab-examined/26925/In this week's DermwireTV, the FDA approves Galderma's Nemluvio for adults with prurigo nodularis; a study examines the long-term use of dupilumab for atopic dermatitis; and Andrew Mastro discusses how to talk to patients about starting a Janus kinase (JAK) inhibitor for AD.Dealing with the Crazy Cost Curve in Dermatologic Drugs
https://practicaldermatology.com/topics/practice-management/dealing-with-the-crazy-cost-curve-in-dermatologic-drugs/20376/Dermatologists, desperate for relief from the forces that have sent prices skyrocketing, are pushing for reform or exploring other options.Late-Stage Drugs for Atopic Dermatitis: An Update
https://practicaldermatology.com/topics/atopic-dermatitis/late-stage-drugs-for-atopic-dermatitis-an-update/23373/Here’s a look at investigational agents for this common disease.Sublative Radiofrequency Improves Skin Texture and Improves Dry Eyes
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sublative-radiofrequency-improves-skin-texture-and-improves-dry-eyes/22075/A popular aesthetic treatment may have an added benefit when used in the periocular area.